Arvaya Healthcare Ltd
Incorporated in 1985, Bijoy Hans Ltd offers medical and lifestyle solutions through physical infrastructure and digital platforms.[1]
- Market Cap ₹ 586 Cr.
- Current Price ₹ 122
- High / Low ₹ 145 / 27.9
- Stock P/E 440
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding is low: 30.6%
- Earnings include an other income of Rs.1.40 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 9.11 | |
| 8.39 | |
| Operating Profit | 0.72 |
| OPM % | 7.90% |
| 1.40 | |
| Interest | 0.41 |
| Depreciation | 0.62 |
| Profit before tax | 1.09 |
| Tax % | 17.43% |
| 0.90 | |
| EPS in Rs | 0.15 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 80% |
| 1 Year: | 358% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| -3.28 | |
| -7.03 | |
| 8.50 | |
| Net Cash Flow | -1.81 |
| Free Cash Flow | -7.94 |
| CFO/OP | -456% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Employee Benefit Expenses (Headcount Proxy) Rupees ・Standalone data |
|
|||||||||
| Interest Income on Deposits Rupees ・Standalone data |
||||||||||
| Non-Current Investments (Investment Portfolio) Rupees ・Standalone data |
||||||||||
| Purchases of Stock-in-Trade Rupees ・Standalone data |
||||||||||
| Revenue Mix: Revenue from Operations as % of Total Revenue % ・Standalone data |
||||||||||
| Stock-in-Trade (Trading Inventory) Rupees ・Standalone data |
||||||||||
| Term Deposits with Banks Rupees ・Standalone data |
||||||||||
| Trade Receivables Rupees ・Standalone data |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper publication for dispatch of the 41st AGM of the company.
-
Announcement Regarding Web Links For Accessing The Notice Of The Forty First Annual General Meeting And Annual Report Of The Company.
- Arvaya Healthcare will hold its 41st AGM on 21 September 2026 via VC/OAVM; notice sent to 3,092 shareholders.
- Notice 41St Annual General Meeting
- Reg. 34 (1) Annual Report.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Advertisement regarding 41st Annual General Meeting of the Company to be held on 21st September 2026 through Video Conference
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
BHL is mainly engaged in the business of trading in bulk drugs, pharmaceuticals, cosmetics, and investments.